European equities traded in the US as American depositary receipts were higher Monday morning, rising 0.38% to 1,537.74 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and pharmaceutical company Novo Nordisk (NVO), which rose 6.2% and 2.4% respectively. They were followed by internet browser company Opera (OPRA) and lender ING (ING), which were up 1.4% and 1.3% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and furniture manufacturer Natuzzi (NTZ), which fell 7.3% and 5% respectively. They were followed by software firm SAP (SAP) and 3D printer company Materialise (MTLS), which were down 2.2% and 1.1% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and NuCana (NCNA), which advanced 12% and 4.3% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and lender Lloyds Banking Group (LYG), which increased 3% and 2.2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Autolus Therapeutics (AUTL), which dropped 4.3% and 3.6% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and pharmaceutical company AstraZeneca (AZN), which lost 3.1% and 2.3% respectively.